Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin applied to the scalp helps treat early-stage hair loss in men and women.

The document suggests more research is needed to understand skin conditions related to toothpaste and other treatments.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Oestrogens are key for bone growth during puberty in both boys and girls.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Oxidative stress contributes to hair graying and loss as we age.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Spironolactone most effective for hirsutism, but has side effects.

Lower SHBG levels may increase the risk of PCOS.